Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Afamelanotide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clinuvel Gets Ema's Final Scientific Advice For Key Vitiligo
    Clinuvel Gets Ema's Final Scientific Advice For Key Vitiligo

    24 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/24/3280522/0/en/clinuvel-receives-final-ema-scientific-advice-for-pivotal-phase-iii-vitiligo-study.html

    GLOBENEWSWIRE
    24 Apr 2026
    Share Share
    Clinuvel recruits 200 patients in Phase III vitiligo trial CUV105
    Clinuvel recruits 200 patients in Phase III vitiligo trial CUV105

    07 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/07/3075714/0/en/CLINUVEL-recruits-200-patients-in-Phase-III-vitiligo-trial-CUV105.html

    GLOBENEWSWIRE
    07 May 2025
    Share Share
    Afamelanotide in fair-skinned Parkinson’s patients
    Afamelanotide in fair-skinned Parkinson’s patients

    17 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/18/2900070/0/en/Afamelanotide-in-fair-skinned-Parkinson-s-patients.html

    GLOBENEWSWIRE
    17 Jun 2024
    Share Share
    Positive final results in stroke
    Positive final results in stroke

    03 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/04/2435187/0/en/Positive-final-results-in-stroke.html

    GLOBENEWSWIRE
    03 May 2022
    Share Share
    Enforcement Report - Week of April 27, 2022
    Enforcement Report - Week of April 27, 2022

    27 Apr 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-27-2022-1651037135.pdf

    FDA
    27 Apr 2022
    Share Share
    Clinuvel enrolls in a world-first study of stroke
    Clinuvel enrolls in a world-first study of stroke

    18 Jan 2022

    // KALKINEMEDIA

    https://kalkinemedia.com/au/news/stock-market/clinuvel-enrolls-in-a-world-first-study-of-stroke

    KALKINEMEDIA
    18 Jan 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.